Brief: Clene Reports Significant Improvement In Vision And Cognition With Cnm-Au8® Treatment

Clene

08/01/2024 14:02

Jan 8 (Reuters) - Clene Inc.  CLNN.O :
    * CLENE REPORTS SIGNIFICANT IMPROVEMENT IN VISION AND
COGNITION
WITH CNM-AU8® TREATMENT IN VISIONARY-MS TRIAL LONG-TERM OPEN
LABEL EXTENSION
    * CLENE INC. - TREATMENT WAS WELL-TOLERATED, WITHOUT A
SINGLE
SERIOUS ADVERSE EVENT ATTRIBUTED TO CNM-AU8 AND NO SIGNIFICANT
SAFETY FINDINGS REPORTED

Source text for Eikon:  ID:nGNX2Hvc2T 
Further company coverage:  CLNN.O 

 ((Reuters.Briefs@thomsonreuters.com;))